FDA Clears Automated Platform for Multiple Myeloma Diagnosis
The system combines enhanced sensitivity with automation to detect M-proteins at low concentrations, supporting early diagnosis of plasma cell disorders.
Read More
Search Results for: liver disease
Multi-Cancer Blood Test Could Significantly Reduce Late-Stage Diagnoses
A simulation model shows that annual liquid biopsy screening would increase early-stage cancer detection by up to 30% while cutting stage IV diagnoses by 45%.
Read More
Blood Test Shows Superior Sensitivity for Early-Stage Liver Cancer Detection
Oncoguard Liver test demonstrates seven times greater sensitivity for very early-stage hepatocellular carcinoma compared to ultrasound surveillance.
Read More
Watchmaker Genomics Launches New Tech Enabling Simultaneous Detection of Methylation and Genetic Variants
TAPS+ chemistry preserves DNA integrity in challenging samples including FFPE tissue and circulating tumor DNA.
Read More
Lab Validates FDA-Cleared Blood-Based Alzheimer’s Biomarker Assay Under EU Regulations
The validation enables its use as a blood-based biomarker for inclusion and exclusion in clinical trials in both the United States and Europe.
Read More